Review Article
Genotyping the High Altitude Mestizo Ecuadorian Population Affected with Prostate Cancer
Table 4
Association of prostate cancer risk with genotype polymorphisms and clinical features.
| Gene | Polymorphism | Genotype | Gleason score | OR | 95% CI | value | Tumor stage | OR | 95% CI | value | 2–6 | 7–10 | T1-T2b | T2c-T4 |
| SRD5A2 | A49T | A/A | 20 | 6 | Reference | 17 | 10 | Reference | A/T + T/T | 36 | 34 | 3.15 | 1.13–8.78 | 0.044 | 26 | 44 | 2.88 | 1.15–7.21 | 0.039 | V89L | V/V | 19 | 24 | Reference | 8 | 36 | Reference | V/L + L/L | 37 | 16 | 0.34 | 0.15–0.79 | 0.020 | 36 | 17 | 0.11 | 0.04–0.27 | 0.000 |
| MTHFR | C677T | C/C | 25 | 5 | Reference | 12 | 15 | Reference | C/T + T/T | 32 | 34 | 5.31 | 1.81–15.56 | 0.003 | 33 | 35 | 0.85 | 0.35–2.08 | 0.895 |
| AR | CAG repeats | ≥22 CAGs | 19 | 8 | Reference | 19 | 8 | Reference | ≤21 CAGs | 27 | 33 | 2.90 | 1.10–7.66 | 0.05 | 20 | 40 | 4.75 | 1.77–12.72 | 0.003 |
|
|
OR, odds ratio.
|